Gihon Telekomunikasi Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Gihon Telekomunikasi Indonesia Tbk. trades at Rp1,675 (market cap 921.25B, 2K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Gihon Telekomunikasi Indonesia Tbk. is far larger — about 8.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GHON | SCPI | |
|---|---|---|
Market Cap | 921.25B | 104.4B |
Volume | 2K | — |
Lot | 20 | — |
Turnover | 3.33M | — |
Average Price | 1,663.25 | — |
Value | 3.33M | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Gihon Telekomunikasi Indonesia Tbk (the Company) was established based on Notarial Deed No. 58 dated April 27, 2001 of Nurmiatri, S.H., notary in Bekasi.
Read more on GHON →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →